Mitchell Steiner is the Chairman, CEO, and President of Veru Inc., a late clinical-stage biopharmaceutical company. Based in Miami, Florida.
Mitchell Steiner is the Chairman, CEO, and President of Veru Inc., a late clinical-stage biopharmaceutical company. He leads the company's drug development program, focusing on novel small molecules like enobosarm and sabizabulin. Veru Inc. develops medicines for cardiometabolic and inflammatory diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library